sabato, 5 dicembre 2020
28 Settembre 2018

FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare disease

September 24, 2018 – The U.S. Food and Drug Administration today announced that it has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to enhance the development of medical products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry across the country. “Developing a treatment for a rare disease can be especially challenging. Given the often small … (leggi tutto)